Catalyst Funds Management Pty »

Pyxis Oncology shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $30k 20k 1.46
2025-06-30 $26k 23k 1.10

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Pyxis Oncology

Pfizer
Laurion Capital Management
Vanguard Group
Vanguard Capital Management
Palo Alto Investors
683 Capital Management
BlackRock
Renaissance Technologies
Geode Capital Management
Longaeva Partners
Jacobs Levy Equity Management
Millennium Management
Marshall Wace
Jane Street
Decheng Capital

View all funds holding Pyxis Oncology